Journal profile · Urology & Nephrology

International Journal of Impotence Research

ISSN 0955-9930 · eISSN 1476-5489 · Springer Nature · ENGLAND · Bimonthly · Founded 1997

International Journal of Impotence Research: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.44; hybrid open access; APC about USD 4,790; median 139 days to acceptance (98 articles, last 24 months); community-reported acceptance: fairly easy; 206 articles in 2025; indexed in SCIE and Scopus.

Impact factor2.44Latest value listed by LetPub
CAS zoneZone 3 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 3 · Medicine
Review time139 daysMedian, submission to acceptance · 98 articles, last 24 months · Crossref
APCUSD 4,790Hybrid journal: charged only for open-access articles
AcceptanceFairly easyCommunity average
Articles per year2062025 · OpenAlex count

Scope

Aims, scope and focus

International Journal of Impotence Research is published by Springer Nature and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sexual function and dysfunction studies, Hormonal and reproductive studies and Sexuality, Behavior, and Technology, together about 57.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Established in 1989, our highly respected journal publishes ground-breaking work, including the first research on Viagra (Sildenafil). We cover the study of sexual dysfunction, addressing sexual medicine for all sexes and genders as an interdisciplinary field. We also publish numerous special features, including Wilson's Workshop, and welcome comments and reviews focusing on key topics. We ensure high visibility for your publication through the nature.com platform. We also provide guidance to authors on how to expand the reach of their work through repositories and our free SharedIt initiative. We offer funder-compliant open access options.

From the journal's Aims & Scope

Research area (LetPub): Urology & Nephrology

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Sexual function and dysfunction studiesMedicine31.4%
  2. Hormonal and reproductive studiesMedicine16.3%
  3. Sexuality, Behavior, and TechnologyPsychology9.7%
  4. Genital Health and DiseaseMedicine8.6%
  5. Urinary Bladder and Prostate ResearchMedicine8.3%
  6. Sexual Differentiation and DisordersBiochemistry, Genetics and Molecular Biology3%
  7. Urological Disorders and TreatmentsMedicine2.8%
  8. Female Genital Mutilation/Cutting IssuesMedicine2.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorUrology & NephrologyZone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorUrology & NephrologyZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorUrology & NephrologyZone 3

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEEmbaseCurrent ContentsPublisher website

Other: Index Medicus

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
2.44LetPub ·
Impact factor (publisher) 2025
2.5Publisher website ·
5-year impact factor (publisher) 2025
2.6Publisher website ·
CiteScore 2026-06
6LetPub ·
SJR 2026-06
0.6LetPub ·
SNIP 2026-06
1.24LetPub ·
h-index
77LetPub ·
h-index
106OpenAlex ·
i10-index
1,589OpenAlex ·
2-year mean citedness
2.26OpenAlex ·
Self-citation rate
24%LetPub ·
Share of gold OA articles
27.66%LetPub ·

Volume

Articles per year
131LetPub ·
Downloads per year (publisher) 2025
1,483,778Publisher website ·

Articles by year OpenAlex count · 3,190 in total · the current year is incomplete

YearArticlesOpen accessCitations
20261394151
202520674410
202419768765
202315545931
2022156511,726
2021114331,487

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

139 daysMedian, submission to acceptance · P25–P75 61 days – 219 days

Acceptance to online
median 15 days (98 articles)
Submission to online
median 156 days
Sample
98 articles with submission and acceptance dates (381 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
over 12 weeksLetPub ·
Average acceptance (community reports)
Fairly easyLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 4,790 / EUR 3,690 / GBP 2,990——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Springer Nature
Country or region
ENGLAND
Language
English
Frequency
Bimonthly
Founded
1997
ISSN
0955-9930
Electronic ISSN
1476-5489
Official links

FAQ

Frequently asked questions about International Journal of Impotence Research

What CAS zone is International Journal of Impotence Research in?

In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of Impotence Research is in Zone 3 of Medicine, and in Zone 3 of the minor category Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of International Journal of Impotence Research?

The latest impact factor listed by LetPub is 2.44; CiteScore 6, h-index 106.

How long does peer review take at International Journal of Impotence Research?

Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 139 days (interquartile range 61–219 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index International Journal of Impotence Research?

According to LetPub and DOAJ records, International Journal of Impotence Research is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase and Current Contents; that list has not been checked against each database.

Is International Journal of Impotence Research open access, and what is the APC?

International Journal of Impotence Research is a hybrid journal. For open-access publication: APC about USD 4,790.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .